PSE Circular for Brokers No. 2241-98

September 28, 1998 PSE CIRCULAR FOR BROKERS NO. 2241-98 SECURITIES AND EXCHANGE COMMISSION SEC FORM 11-C CURRENT REPORT UNDER SECTION 11 OF THE REVISED SECURITIES ACT (RSA) AND RSA RULE 11(a)-1(b)(3)THEREUNDER 1. September 23, 1998 Date of Report (Date of earliest event reported) 2. SEC Identification Number 148022 3. Tax Identification No. 360-000-288-655-V 4. EURO-MED LABORATORIES PHIL., INC. Exact name of registrant as specified in its charter 5. Metro Manila, Philippines Province, country or other jurisdiction of incorporation 6. (SEC Use Only) Industry Classification Code: 7. PPL Bldg., 1000 United Nations Avenue corner San Marcelino St., Manila 1000 Address of principal office Postal Code 8. 63-2-254-0091 to 98 Registrant's telephone number, including area code 9. Not applicable Former name or former address, if changed since last report 10. Securities registered pursuant to Sections 4 and 8 of the RSA Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding Common Stock 800,000,000 shares 11. Indicate the item numbers reported herein: Item 4. Election/Appointment of New Officers At the regular meting of the Board of Directors of the Corporation held on September 23, 1998 at its principal office, the following officers were duly appointed and promoted to higher ranks: Name of Officer Position Date of Effectivity of Appointment Carlos G. Atendido Vice President For October 1, 1998 Export Sales Celso A. Velasquez Vice President and October 1, 1998 National Sales Manager Leonardo H. Toribio Vice President and October 1, 1998 National Distribution Manager Pursuant to the requirements of the Revised Securities Act, Euro-Med Laboratories Phil., Inc. has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized. September 25, 1998 EURO-MED LABORATORIES PHIL., INC. (SGD.) RONNIE G. RAGONTON Corporate Secretary